Biolase Reports Q2 Earnings: EPS and Revenue Fall Short of Expectations
Thursday, 8 August 2024, 22:04
Biolase Q2 Earnings Overview
Biolase (BIOL) has unveiled its Q2 earnings, showcasing a series of challenges for the company.
Earnings and Revenue Performance
- GAAP EPS: -$0.08, missing expectations by $0.01
- Revenue: $11.56 million, falling short by $1.94 million
Gross Margin Insights
Despite the lower earnings and revenue figures, Biolase reported a gross margin of 40% globally.
Conclusion
The Q2 report from Biolase highlights significant misses in both earnings and revenue, raising questions about the company’s future trajectory.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.